KYABRS implementing effective risk mitigation at study start is a focus for the CRA team. Multifunctional and communicative relationships across Clinical Operations serve as the backbone for CRAs, and the monitoring emphasis is rooted in subject safety, data integrity, and risk assessment. KYABRS understand the study objectives, efficacy and safety variables, and the Lead CRA outlines how the CRA team should proactively identify and manage the study according to critical data and processes. With the oversight, support, and training from Clinical Trial Management, CRA teams use site quality indicators to emphasize patient safety and data integrity. We create a centralized monitoring plan review team within Clinical Monitoring so our approach is consistent, yet flexible enough for study-specific considerations and implementation. KYABRS Mitigation Risk through Real-time Metrics, System and Process Efficiencies.